RecruitingNCT06000527
Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA ")
Sponsor
Imagine Institute
Enrollment
200 participants
Start Date
Oct 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Recurrent respiratory papillomatosis (RRP) is a rare disease. However, it is the most common benign laryngeal tumor in children. To date, no epidemiological data are available in France. The aim of this study is to establish the epidemiology of juvenile PPR.
Eligibility
Inclusion Criteria5
- Patients with juvenile PRR (disease onset before age 18)
- Followed in the :
- The MALO CRMR
- One of the MALO network's CCMRs
- One of the main correspondent centers
Exclusion Criteria2
- Patients objecting to the collection of their personal data
- Parents of minor patients objecting to the collection of their child's personal data
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06000527